Skip to main content
DRUG logo

Bright Minds Biosciences Inc.

DRUGNASDAQHealthcareBiotechnology

$55.32Today:- (-)1Y −14.38%

As of Oct 28, 2026 close

Market cap
$543.82M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$47.23$123.75
Volume (live)
-
Avg. volume (3M)
135.74K

Bright Minds Biosciences Inc. (DRUG) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Bright Minds Biosciences Inc. stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Buy
Based on 5 unique analysts
(6 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$165.25
+198.72% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest DRUG Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Rudy Li
Wolfe Research
BuyInitiates
$150.00
Francois Brisebois
LifeSci Capital
BuyInitiates
$146.00
Yasmeen Rahimi
Piper Sandler
BuyMaintains
$220.00
Patrick Trucchio
HC Wainwright
BuyMaintains
$145.00
Joseph Thome
TD Cowen
BuyMaintains
-
Joseph Thome
TD Cowen
BuyMaintains
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 15, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for DRUG?

The analyst consensus rating for DRUG is Buy, based on the latest ratings from 5 analysts over the last 90 days.

What is the average price target for DRUG?

The average 12-month price target for DRUG is $165.25, representing an upside of 198.7% from the Oct 28, 2026 close of $55.32.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.